Literature DB >> 16323117

Vancomycin: a 50-year reassessment.

Robert C Moellering1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16323117     DOI： 10.1086/491708

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  74 in total

Review 1.  Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.

Authors:  Sepideh Elyasi; Hossein Khalili; Simin Dashti-Khavidaki; Amirhooshang Mohammadpour
Journal:  Eur J Clin Pharmacol       Date:  2012-03-13       Impact factor: 2.953

Review 2.  Risk of hepatic events in patients treated with vancomycin in clinical studies: a systematic review and meta-analysis.

Authors:  Yan Chen; Xiao Yan Yang; Michael Zeckel; Chris Killian; Kenneth Hornbuckle; Arie Regev; Simon Voss
Journal:  Drug Saf       Date:  2011-01-01       Impact factor: 5.606

3.  Rutin Attenuates Vancomycin-Induced Nephrotoxicity by Ameliorating Oxidative Stress, Apoptosis, and Inflammation in Rats.

Authors:  Shaoqi Qu; Cunchun Dai; Fengting Lang; Longfei Hu; Qihe Tang; Haixia Wang; Yanping Zhang; Zhihui Hao
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 4.  Antimicrobials: Strategies for targeting obesity and metabolic health?

Authors:  Eileen F Murphy; Siobhan F Clarke; Tatiana M Marques; Colin Hill; Catherine Stanton; R Paul Ross; Robert M O'Doherty; Fergus Shanahan; Paul D Cotter
Journal:  Gut Microbes       Date:  2012-09-27

5.  Isolation and identification of lipopeptide antibiotics from Paenibacillus elgii B69 with inhibitory activity against methicillin-resistant Staphylococcus aureus.

Authors:  Rui Ding; Xue-Chang Wu; Chao-Dong Qian; Yi Teng; Ou Li; Zha-Jun Zhan; Yu-Hua Zhao
Journal:  J Microbiol       Date:  2011-12-28       Impact factor: 3.422

Review 6.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

7.  Appropriate antibiotic dosage levels in the treatment of severe sepsis and septic shock.

Authors:  Fabio Silvio Taccone; Maya Hites; Marjorie Beumier; Sabino Scolletta; Frédérique Jacobs
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

8.  Vancomycin Pharmacokinetics in Patients with Advanced Cancer Near End of Life.

Authors:  Hirokazu Nakayama; Masahiro Suzuki; Toshiaki Kato; Hirotoshi Echizen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-12       Impact factor: 2.441

9.  Vancomycin-Associated Acute Kidney Injury in a Large Veteran Population.

Authors:  Geeta Gyamlani; Praveen K Potukuchi; Fridtjof Thomas; Oguz Akbilgic; Melissa Soohoo; Elani Streja; Adnan Naseer; Keiichi Sumida; Miklos Z Molnar; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Am J Nephrol       Date:  2019-01-24       Impact factor: 3.754

10.  Real-time PCR testing for mecA reduces vancomycin usage and length of hospitalization for patients infected with methicillin-sensitive staphylococci.

Authors:  David T Nguyen; Ellen Yeh; Sharon Perry; Robert F Luo; Benjamin A Pinsky; Betty P Lee; Deepak Sisodiya; Ellen Jo Baron; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.